Advertisement
Screener

Edwards Lifesciences Corporation (EW) Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent

2.8 / 5 stars · 68/120 Roast Me

Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent

Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent of $400.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-28.

Discontinued › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent · last filed 2013-02-28

  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for the quarter ending 2012-12-31 was $400.00K, a 93.22% decline year-over-year.
  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for the quarter ending 2012-09-30 was -$5.90M, a 151.75% decline year-over-year.
  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for the quarter ending 2012-06-30 was $3.30M.
  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for the quarter ending 2012-03-31 was $2.60M.
  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2012 was $400.00K, a 96.23% decline from fiscal 2011.
  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2011 was $10.60M.
  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2010 was -$4.40M, a 291.30% decline from fiscal 2009.
  • Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, tax, portion attributable to parent for fiscal 2009 was $2.30M.
Period endOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 3 month as first filedOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 9 month as first filedOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 12 monthOther Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent 12 month as first filed
2012-12-31$400.00K
derived: 10-K 12 month − 3 quarters · filed 2013-02-28
-$5.50M
derived: sum of 2 quarters · filed 2013-02-28
-$2.20M
derived: sum of 3 quarters · filed 2013-02-28
$400.00K
10-K · filed 2013-02-28
2012-09-30-$5.90M
10-Q · filed 2012-11-07
-$2.60M
derived: sum of 2 quarters · filed 2012-11-07
$0.00
derived: sum of 3 quarters · filed 2012-11-07
$5.90M
derived: sum of 4 quarters · filed 2013-02-28
2012-06-30$3.30M
10-Q · filed 2012-08-07
$5.90M
10-Q · filed 2012-08-07
$11.80M
derived: sum of 3 quarters · filed 2013-02-28
$23.20M
derived: sum of 4 quarters · filed 2013-02-28
2012-03-31$2.60M
10-Q · filed 2012-05-09
$8.50M
derived: sum of 2 quarters · filed 2013-02-28
$19.90M
derived: sum of 3 quarters · filed 2013-02-28
$18.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-12-31$5.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$17.30M
derived: sum of 2 quarters · filed 2013-02-28
$15.40M
derived: sum of 3 quarters · filed 2013-02-28
$10.60M
10-K · filed 2013-02-28
-$10.60M
10-K · filed 2012-02-27
2011-09-30$11.40M
10-Q · filed 2012-11-07
-$11.40M
10-Q · filed 2011-11-08
$9.50M
derived: sum of 2 quarters · filed 2012-11-07
$4.70M
10-Q · filed 2012-11-07
-$4.70M
10-Q · filed 2011-11-08
-$2.10M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30-$1.90M
10-Q · filed 2012-08-07
-$6.70M
10-Q · filed 2012-08-07
-$13.50M
derived: sum of 3 quarters · filed 2013-02-28
-$2.10M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31-$4.80M
10-Q · filed 2012-05-09
-$11.60M
derived: sum of 2 quarters · filed 2013-02-28
-$200.00K
derived: sum of 3 quarters · filed 2013-02-28
2010-12-31-$6.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$4.60M
derived: sum of 2 quarters · filed 2013-02-28
-$4.40M
10-K · filed 2013-02-28
$4.40M
10-K · filed 2012-02-27
2010-09-30$11.40M
10-Q · filed 2011-11-08
$2.40M
10-Q · filed 2011-11-08
2009-12-31$2.30M
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00